HPC
CVS icon

HM Payson & Co’s CVS Health CVS Stock Holding History

HM Payson & Co’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2M Sell
19,373
-5,067
-21% -$452K 0.03% 167
2026
Q1 		$1.76M Buy
24,440
+3,285
+16% +$253K 0.03% 169
2025
Q4 		$1.68M Sell
21,155
-114
-0.5% -$8.99K 0.02% 171
2025
Q3 		$1.6M Sell
21,269
-263
-1% -$18K 0.02% 173
2025
Q2 		$1.49M Buy
21,532
+603
+3% +$39.5K 0.02% 174
2025
Q1 		$1.42M Sell
20,929
-1,342
-6% -$80.3K 0.02% 176
2024
Q4 		$1,000K Sell
22,271
-12,119
-35% -$680K 0.02% 212
2024
Q3 		$2.16M Sell
34,390
-3,500
-9% -$204K 0.04% 148
2024
Q2 		$2.24M Sell
37,890
-264,036
-87% -$16.5M 0.04% 144
2024
Q1 		$24.1M Buy
301,926
+153,163
+103% +$11.7M 0.45% 56
2023
Q4 		$11.7M Buy
148,763
+70,061
+89% +$4.99M 0.24% 73
2023
Q3 		$5.49M Sell
78,702
-6,633
-8% -$470K 0.13% 94
2023
Q2 		$5.9M Sell
85,335
-341,887
-80% -$24.3M 0.13% 89
2023
Q1 		$31.7M Sell
427,222
-564,084
-57% -$47.3M 0.76% 44
2022
Q4 		$92.4M Buy
991,306
+160,896
+19% +$15.5M 2.3% 10
2022
Q3 		$79.2M Buy
830,410
+40,766
+5% +$4.04M 2.17% 10
2022
Q2 		$73.2M Buy
789,644
+36,895
+5% +$3.6M 1.88% 14
2022
Q1 		$76.2M Buy
752,749
+50,434
+7% +$5.3M 1.73% 16
2021
Q4 		$72.5M Buy
702,315
+532,016
+312% +$49.2M 1.57% 19
2021
Q3 		$14.5M Buy
170,299
+132,348
+349% +$11.1M 0.35% 66
2021
Q2 		$3.17M Sell
37,951
-449
-1% -$36.8K 0.08% 135
2021
Q1 		$2.89M Sell
38,400
-1,311
-3% -$95.5K 0.08% 136
2020
Q4 		$2.71M Sell
39,711
-76
-0.2% -$4.94K 0.08% 140
2020
Q3 		$2.32M Buy
39,787
+264
+0.7% +$16.4K 0.07% 136
2020
Q2 		$2.57M Sell
39,523
-1,482
-4% -$93.3K 0.09% 127
2020
Q1 		$2.43M Buy
41,005
+1,630
+4% +$109K 0.1% 116
2019
Q4 		$2.92M Buy
39,375
+6,774
+21% +$476K 0.09% 120
2019
Q3 		$2.06M Sell
32,601
-1,314
-4% -$77.9K 0.07% 138
2019
Q2 		$1.85M Sell
33,915
-1,011
-3% -$54.4K 0.07% 145
2019
Q1 		$1.88M Buy
34,926
+34,251
+5,074% +$2.11M 0.07% 140
2018
Q4 		$44K Sell
675
-29,794
-98% -$2.22M 0.13% 88
2018
Q3 		$2.4M Sell
30,469
-1,520
-5% -$109K 0.11% 126
2018
Q2 		$2.06M Buy
31,989
+441
+1% +$29.1K 0.09% 134
2018
Q1 		$1.96M Sell
31,548
-409
-1% -$29.3K 0.08% 143
2017
Q4 		$2.32M Sell
31,957
-267
-0.8% -$19.4K 0.09% 138
2017
Q3 		$2.62M Sell
32,224
-687
-2% -$54.3K 0.11% 127
2017
Q2 		$2.65M Sell
32,911
-6,370
-16% -$503K 0.12% 123
2017
Q1 		$3.08M Buy
39,281
+4,106
+12% +$328K 0.14% 113
2016
Q4 		$2.77M Buy
35,175
+349
+1% +$28.2K 0.13% 118
2016
Q3 		$3.1M Sell
34,826
-134
-0.4% -$12.6K 0.15% 112
2016
Q2 		$3.35M Buy
34,960
+366
+1% +$36.5K 0.17% 104
2016
Q1 		$3.59M Buy
34,594
+470
+1% +$45.7K 0.19% 100
2015
Q4 		$3.34M Buy
34,124
+773
+2% +$75.7K 0.17% 110
2015
Q3 		$3.22M Buy
33,351
+450
+1% +$47.3K 0.17% 109
2015
Q2 		$3.45M Sell
32,901
-134
-0.4% -$13.7K 0.17% 110
2015
Q1 		$3.41M Sell
33,035
-923
-3% -$93.4K 0.17% 112
2014
Q4 		$3.27M Buy
33,958
+23
+0.1% +$2.03K 0.16% 111
2014
Q3 		$2.7M Sell
33,935
-1,183
-3% -$93.3K 0.14% 116
2014
Q2 		$2.65M Buy
35,118
+125
+0.4% +$9.45K 0.14% 119
2014
Q1 		$2.62M Sell
34,993
-35
-0.1% -$2.47K 0.14% 120
2013
Q4 		$2.51M Sell
35,028
-49
-0.1% -$3.15K 0.13% 123
2013
Q3 		$1.99M Buy
35,077
+649
+2% +$38.7K 0.12% 131
2013
Q2 		$1.97M Buy
+34,428
New +$1.99M 0.12% 127

Other funds holding CVS

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
CAM
Cacti Asset Management Atlanta, Georgia $1.99B AUM 86.33% 1-Year Est. Return

HM Payson & Co's CVS Position: Q2 2026 in Review

HM Payson & Co reduced its CVS Health (CVS) stake by 21% in Q2 2026, selling an estimated $452K and leaving 19,373 shares worth $2M. The position accounts for 0.03% of the portfolio, ranked #167.

HM Payson & Co first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $92.4M in Q4 2022. 399 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • HM Payson & Co held 19,373 shares of CVS Health worth $2M as of Q2 2026.
  • HM Payson & Co sold 5,067 CVS Health shares in Q2 2026, an estimated $452K.
  • CVS Health made up 0.03% of HM Payson & Co's portfolio in Q2 2026, its #167 holding.
  • HM Payson & Co first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
  • HM Payson & Co's CVS Health position peaked at $92.4M in Q4 2022.
  • 399 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on HM Payson & Co's 13F filing for Q2 2026, filed 17 Jul 2026.